Abstract
The binding properties of Pseudomonas aeruginosa agglutinin-I (PA-IL) with glycoproteins (gps) and polysaccharides were studied by both the biotin/avidin-mediated microtiter plate lectin-binding assay and the inhibition of agglutinin-glycan interaction with sugar ligands. Among 36 glycans tested for binding, PA-IL reacted best with two glycoproteins containing Galα1→4Gal determinants and a human blood group ABO precursor equivalent gp, but this lectin reacted weakly or not at all with A and H active gps or sialylated gps. Among the mammalian disaccharides tested by the inhibition assay the human blood group P(k) active Galα1→4Gal, was the best. It was 7.4-fold less active than melibiose (Galα1→6Glc). PA-IL has a preference for the cα-anomer in decreasing order as follows: Galα1→6 > Galα1→4 > Galα1→3. Of the monosaccharides studied, the phenylβ derivatives of Gal were much better inhibitors than the methylβ derivative, while only an insignificant difference was found between the Galα anomer of methyl- and p-NO2-phenyl derivatives. From these results, it can be concluded that the combining size of the agglutinin is as large as a disaccharide of the α-anomer of Gal at nonreducing end and most complementary to Galα1→6Glc. As for the combining site of PA-IL toward the β-anomer, the size is assumed to be less than that of Gal; carbon-6 in the pyranose form is essential, and hydrophobic interaction is important for binding.
| Original language | English |
|---|---|
| Pages (from-to) | 7-16 |
| Number of pages | 10 |
| Journal | Glycobiology |
| Volume | 8 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1998 |
Bibliographical note
Funding Information:This work was supported by Grants from the Chang-Gung Medical Research Project (CMRP No. 676), Kwei-san, Tao-yuan, Taiwan and the National Science Council (NSC 86–2316-B182–001-BC and 84–2811-B182–001R), the National Health Institutes (DOH 85-HR-316 and DOH 84-HR-209), Department of Health, Taipei, Taiwan.
Funding
This work was supported by Grants from the Chang-Gung Medical Research Project (CMRP No. 676), Kwei-san, Tao-yuan, Taiwan and the National Science Council (NSC 86–2316-B182–001-BC and 84–2811-B182–001R), the National Health Institutes (DOH 85-HR-316 and DOH 84-HR-209), Department of Health, Taipei, Taiwan.
| Funders | Funder number |
|---|---|
| CMRP | 676 |
| Chang-Gung Medical Research Project | |
| National Science Council | NSC 86–2316-B182–001-BC, 84–2811-B182–001R |
| Department of Health, Australian Government | |
| National Health Research Institutes | DOH 84-HR-209, DOH 85-HR-316 |
Keywords
- Binding properties
- Combining sites
- Glycoproteins
- Lectin
- Pseudomonas aeruginosa